Melanie Morel-Ferris
Keine laufenden Positionen mehr
Profil
Melanie Morel-Ferris worked as a Corporate Controller at Astrodyne Corp.
from 2014 to 2016, an Associate Director-Accounting at ARIAD Pharmaceuticals, Inc. in 2014, and a Senior Director-Finance & Controller at Invivo Therapeutics Holdings Corp.
in 2017.
She obtained an undergraduate degree from Assumption College.
Ehemalige bekannte Positionen von Melanie Morel-Ferris
Unternehmen | Position | Ende |
---|---|---|
INVIVO THERAPEUTICS HOLDINGS CORP. | Finanzdirektor/CFO | 29.03.2017 |
Astrodyne Corp.
Astrodyne Corp. Electrical ProductsProducer Manufacturing Astrodyne Corp. manufactures switching power supply and converters. The firm’s products include power supplies and EMI filters for industrial, semiconductor manufacturing, medical, consumer appliance, military, and aerospace sectors. The company was founded in 1994 and is headquartered in Mansfield, MA. | Comptroller/Controller/Auditor | 01.05.2016 |
ARIAD PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.07.2014 |
Ausbildung von Melanie Morel-Ferris
Assumption College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
Private Unternehmen | 2 |
---|---|
Astrodyne Corp.
Astrodyne Corp. Electrical ProductsProducer Manufacturing Astrodyne Corp. manufactures switching power supply and converters. The firm’s products include power supplies and EMI filters for industrial, semiconductor manufacturing, medical, consumer appliance, military, and aerospace sectors. The company was founded in 1994 and is headquartered in Mansfield, MA. | Producer Manufacturing |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |